RecruitingEarly Phase 1NCT07017023

Combined Blood Pressure Medication and Activity Scheduling for Low Mood

Cognitive Effects of Losartan-augmented Behavioural Activation in Anhedonia


Sponsor

University of Oxford

Enrollment

76 participants

Start Date

Jul 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study explores the effects of 7-day losartan (50mg) versus placebo with brief behavioural activation on emotional processing in young volunteers low in positive mood


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether a blood pressure medication combined with a behavioral therapy technique (activity scheduling) can improve low mood and positive emotions in people who are feeling persistently down but do not have a severe depression diagnosis. **You may be eligible if...** - You are between 18 and 65 years old - You have self-reported low levels of positive mood - You have access to a computer with a reliable internet connection - You have normal or corrected vision and hearing - You have not taken antidepressants in the last 3 months **You may NOT be eligible if...** - You have a history of psychosis, bipolar disorder, or substance dependence - You are currently at clinical risk of suicide or have a history of suicide attempts - You are currently taking blood pressure or heart medication - You have very low blood pressure (below 90/60 mmHg) - Your depression score is severe (BDI-II score above 30) - You have a significant neurological disorder (e.g., epilepsy) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLosartan with BA

7-day losartan (Cozaar, 50mg; oral tablet) with 7-day BA

OTHERPlacebo with BA

7-day placebo (oral; microcellulose in identical capsules) with 7-day BA


Locations(1)

Warneford Hospital, University of Oxford

Oxford, Oxfordshire, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07017023


Related Trials